Life Sciences and Healthcare

Life sciences & Healthcare Subtitle

Currently, on an upward growth curve, the industry is expected to touch £123 billion in revenues by 2018, up from £61 billion in 2013, demonstrating a CAGR of 15% for 2013–18. An increasingly affluent population is spending on private healthcare, and Indian pharma and biotech companies are increasing investments and growing internationally. Indian government recently permitted FDI up to 100% under the automatic route for manufacturing of medical devices and the liberalisation of the insurance industry in India will also boost healthcare insurance.

Latest News

Case studies

View More

Get a free consultation with one of our India Advisers